Coronavirus

Pfizer COVID-19 vaccine clears Japan panel for use with young children

Published: Updated:
Enable Read mode
100% Font Size

A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc’s COVID-19 vaccine for children as young as six months old.

Japan in January expanded use of the vaccine to those as young as 5 years old.

For all the latest headlines follow our Google News channel online or via the app.

Last month, health authorities started to dispensing Pfizer and Moderna Inc booster shots that target the Omicron variant of the virus.

Both companies have versions of the vaccine that are further refined to defend against the BA.4 and BA.5 subvariants of Omicron.

Moderna said on Wednesday it was seeking Japanese approval of its subvariant shot, following Pfizer’s application last month.

Read more:

WHO says COVID-19 pandemic end in sight, China disagrees

Moderna refused China’s request to reveal technology behind its COVID-19 vaccine

Japan’s COVID-19 herd immunity level near 90 percent after omicron wave: Study

Top Content Trending